The most common side effects reported in trials are gastrointestinal in nature, nausea, reduced appetite, and occasional digestive discomfort, particularly at the start of treatment and during dose escalation
[6] [9] According to NICE guidance (NG28), GLP-1 receptor agonists are recommended as part of a comprehensive treatment strategy for type 2 diabetes that includes dietary modification, increased physical activity, and other glucose-lowering therapies when appropriate
How to draw your solution Before your first use, take the time to review how to properly draw your solution
According to the American Association of Clinical Endocrinologists and American College of Endocrinology (AACE/ACE) Obesity Clinical Practice Guidelines, weight loss medications should be offered as chronic treatment along with lifestyle modifications to patients with obesity when the potential benefits outweigh the risks
To get expert advice and take a well-informed step, patients can reach out to TrimBody M.D for safe care